TSXV:CDX

Maple, Cloud DX and Curatio Announce Canada-Wide COVID-19 Home Monitoring Program

Maple, Cloud DX and Curatio Announce Canada-Wide COVID-19 Home Monitoring Program

Cloud DX (TSXV:CDX) a leading Canadian provider of virtual care and remote patient monitoring solutions announced today it is joining forces with fellow virtual care providers Maple and Curatio to create a new Canada-wide COVID-19 home monitoring program that will allow Canadian healthcare organizations to ‘decant' COVID-19 patients to their homes equipped with remote automated monitoring technology, efficient clinical oversight and daily disease management support via virtual care

The Canada-wide Virtual COVID-19 Outpatient Program (VCOP) brings together three core elements into one integrated COVID-19 virtual care program:

  • Key vital signs monitoring via Cloud DX's Connected Health Kit (wireless pulse oximeter, wireless thermometer, the Pulsewaveâ„¢ blood pressure cuff, Cloud DX mobile app and clinical portal).

  • Clinical oversight from Canadian-licensed physicians on the Maple virtual care platform, to monitor patient vital signs, triage patient condition and make treatment recommendations should COVID-19 symptoms worsen.

  • Coaching and support through Curatio's Stronger Together secure, moderated support network to connect patients to daily evidence-based programs, community resources, mental health and psychosocial support.

"We're at a critical stage right now, especially with new variants of concern which are exacerbating the resource challenges that hospitals are already facing," says Brett Belchetz, CEO and Co-founder, Maple. "We're pleased to partner on this innovative remote patient monitoring program to support healthcare facilities in coping with the influx of COVID-19 patients."

"As CEOs of three of Canada's most prominent virtual care companies, we cannot stand by as our country battles the worst health crisis in a century. It was critically important to all of us to find a solution to mitigate the potential human catastrophe we see unfolding in our hospitals," says Robert Kaul, CEO of Cloud DX. "We are actively petitioning Provincial health ministries, starting with Ontario Health, for VCOP adoption for a minimum of 90 days to help healthcare providers manage through this third wave crisis."

"We already have thousands of patients with long COVID benefiting from our platform along with patients awaiting surgery, battling chronic conditions and mental health challenges," says Lynda Brown-Ganzert, CEO of Curatio. "We are a Canadian-made answer, ready to be deployed to help ease this COVID-19 crisis. As leaders, we have quickly banded together to help support our healthcare systems, authorities, government and most importantly, our fellow Canadian patients and families. Our solutions are trusted worldwide and it's time to utilize them, right here at home, for the urgent challenges we face."

"Virtual care and remote home monitoring are game changers when it comes to how we care for patients," says Dr. Mohamed Panju, site chief for HHS Hamilton General Hospital, where one of the hospital's COVID units is located. Dr. Panju is also a physician lead for the remote home monitoring program at HHS. "Remote home monitoring creates a safety net for patients recovering at home and it helps prevent return trips to the emergency department since the virtual care team can help with health concerns that might arise," he said.

Cloud DX, Maple and Curatio have agreed to share revenues earned under this joint program, wherein each company will offer best available pricing. Cloud DX has many commercial deployments of the Connected health System in Canada, including contracts with Provincial and Territorial governments, hospital systems in Ontario and Alberta and commercial partners. The Curatio platform is used in 104 countries, is available in 20 languages, and is the only privacy and regulatory compliant social platform for patients. Maple is Canada's industry leading virtual care platform, supporting multiple hospitals across the Greater Toronto Area with COVID-19 response virtual care programs.

About Maple

Maple is a technology platform that tackles some of the world's most meaningful issues in healthcare, starting with timely and convenient access to doctors and other healthcare providers including dermatologists, psychiatrists, and oncology navigation experts. It allows patients to connect directly with doctors and specialists for medical care in minutes from their smartphone or computer 24/7, and also provides custom technology solutions for employers, insurers, hospitals, and clinics. Learn more at getmaple.ca.

About Cloud DX

Accelerating virtual healthcare's future Cloud DX is making healthcare better for everyone. The company's Connected Health remote patient monitoring platform is used by healthcare enterprises and care teams across North America to virtually manage chronic disease, enable ageing in place and deliver hospital-quality post-surgical care. Providers partnering with Cloud DX achieve better healthcare and patient outcomes, reduce the need for hospitalization/re-hospitalization and reduce the costs of healthcare delivery through more efficient use of resources. Cloud DX is the co-winner of the Qualcomm Tricorder XPRIZE, a 2021 Edison Award winner, a Fast Company "World Changing Idea" finalist and one of Canada's 10 most prominent Telehealth providers.

For More Information on Cloud DX - Join Us on Zoom Today - Register Here https://zoom.us/webinar/register/WN_5Ao0f3KmTA-MhhnD5JwHSQ

About Curatio

Curatio enables payers, providers, researchers and pharmaceutical manufacturers to compliantly engage with patients on their own social networks. Curatio provides a private, secure social network platform that uses proprietary algorithms, AI and machine learning to match patients to the peer support, programs and daily management tools that help them live their healthiest lives. Used in 104 countries, available in 20 languages, Curatio has won numerous awards for its unique technical solution and its mission of No Patient Alone. Download the Stronger Together app at https://curatio.me/stronger-together/

# # #

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For media inquiries please contact:

Aliya Darvesh
Senior Manager Communications, Maple
aliya.darvesh@getmaple.ca

Ellyn Winters-Robinson
Ignition Communications (PR for Cloud DX)
519-574-2196
ellyn@ignition.ca

For Cloud DX investor inquiries please contact:

Jay Bedard
Cloud DX Investor Relations
647-881-8418
jay.bedard@CloudDX.com

For More Information on Cloud DX - Join Us on Zoom Today, April 28, 2021 at 2pm EST - Register Here: https://zoom.us/webinar/register/WN_5Ao0f3KmTA-MhhnD5JwHSQ

Valerie Stachurski
Brand Manager, Curatio Networks Inc.
416-520-9504
valerie@curatio.me

SOURCE:Cloud DX Inc.



View source version on accesswire.com:
https://www.accesswire.com/642775/Maple-Cloud-DX-and-Curatio-Announce-Canada-Wide-COVID-19-Home-Monitoring-Program

News Provided by ACCESSWIRE via QuoteMedia

The Conversation (0)
SEC website on phone screen.

SEC Reopens Investigation on Neuralink and Musk’s Twitter Deal

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant company, alongside a probe into Musk’s acquisition of Twitter, now rebranded as X.

A letter from Musk’s lawyer, Alex Spiro, disclosed the development on Thursday (December 12), raising questions about the ongoing legal disputes between Musk and the SEC, according to a Reuters report.

The letter, addressed to outgoing SEC Chair Gary Gensler, outlines the reopening of the Neuralink investigation and a settlement demand regarding the Twitter takeover, which happened in 2022.

Keep reading...Show less
Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to announce that it has more than doubled the acreage on the recently acquired George Lake South Antimony Project in New Brunswick, Canada. This project now consists of 4,722 contiguous acres prospective for antimony.

James Nelson, President of Spearmint, stated, "In light of the recent ban of antimony by China to the USA, we made this strategic acquisition increasing the size of the George Lake South Antimony Project. Management feels that antimony will be one of the most sought after resources in 2025 and we plan to pursue this space with vigor and are currently evaluating additional projects. Management is formulating a plan on the George Lake South Antimony Project, and management also intends to update the market on Spearmint's crypto diversification plan in the near future as well. These are truly exciting times for Spearmint and Spearmint shareholders."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Spearmint Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike

Spearmint Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to provide an update to shareholders on the impact of the strike by the Canadian Union of Postal Workers on the Company's ability to comply with its obligations to deliver to shareholders its financial statements and related disclosure and proxy-related materials in respect of the Company's annual general meeting of shareholders (the "Meeting") scheduled to be held at Cozen O'Connor LLP - 550 Burrard Street, Suite 2501, Vancouver, B.C., on Thursday, Dec. 19, 2024, at 10 a.m. PST.

James Nelson, President of Spearmint stated, "We want all of our shareholders to be aware of the current situation as there are many exciting events occurring for Spearmint in the short and medium term."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
RETRANSMISSION: Spearmint Comments on China's Ban of Critical Mineral Exports to the USA, including Antimony

RETRANSMISSION: Spearmint Comments on China's Ban of Critical Mineral Exports to the USA, including Antimony

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to comment on yesterday's announcement of China banning exports of critical minerals including antimony to the United States. As trade tensions escalate between the USA and China, this move clearly emphasizes the urgent need for Western nations to secure reliable long-term sources of these critical minerals which are now at the forefront of the global supply chain crisis.

Antimony is an essential component in semi-conductors, battery storage technology, and has several military applications. Prices of antimony trioxide in Rotterdam had soared by 228% since the beginning of the year to $39,000 a metric ton on Nov. 28, data from information provider Argus showed(1). The move is a considerable escalation of tensions in supply chains where access to raw material units is already tight in the West(1).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×